(Q53908631)
Statements
Efficacy and tolerability of a low-dose of Oesclim (25 mcg daily) in the management of symptomatic menopausal women: a French open-label study. (English)
Elia D
Tamborini A
Leocmach Y
Chadha-Boreham H
1 January 2000
16
2
94-106